Bausch + Lomb names Thomas J. Appio interim CEO
Bausch + Lomb and Bausch Health appointed Thomas J. Appio interim CEO and said they expect to raise the company’s full-year 2026 guidance.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Dow Jones Newswires reports that Bausch + Lomb and Bausch Health announced the appointment of Thomas J. Appio as interim chief executive officer of Bausch + Lomb.
The companies also expect to raise Bausch + Lomb’s full-year 2026 guidance.
why it matters
A leadership appointment alongside a potential guidance increase represents a significant corporate development that may affect how market participants assess Bausch + Lomb shares.
instruments
sources
- Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance >BLCO — Dow Jones Newswires, 12 October 2026 at 10:45 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗